An update on the use of NOD mice to study autoimmune (Type 1) diabetes

The widely used nonobese diabetic (NOD) mouse model of autoimmune (Type 1) diabetes mellitus shares multiple characteristics with the human disease and studies employing this model continue to yield clinically relevant and important information Here, we review some of the recent key findings obtained from NOD mouse investigations that have both advanced our understanding of disease pathogenesis and suggested new therapeutic targets and approaches Areas discussed include antigen discovery identification of genes and pathways contributing to disease susceptibility development of strategies to image islet inflammation and the testing of therapeutics We also review recent technical advances that combined with an improved understanding of the NOD mouse model s limitations should work to ensure its popularity utility and relevance in the years ahead